Efficacy and side effect profile of varying doses of intrathecal fentanyl added to bupivacaine for labor analgesia

Cynthia A. Wong*, B. M. Scavone, J. P. Slavenas, M. I. Vidovich, Alan M Peaceman, J. N. Ganchiff, T. Strauss-Hoder, Robert J McCarthy

*Corresponding author for this work

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The purpose of this randomized, double blinded and controlled study was to determine the optimal dose of intrathecal fentanyl when combined with bupivacaine 2.5 mg for initiation of labor analgesia. Parous parturients with cervical dilation between 3 and 5 cm were randomized to receive intrathecal fentanyl 0 (control), 5, 10, 15, 20 or 25 μg, combined with bupivacaine 2.5 mg, followed by a lidocaine/epinephrine epidural test dose. Visual analog pain scores (VAPS) and the presence of side effects were determined every 15 min until the parturient requested additional analgesia. Fetal heart rate (FHR) tracings were compared between groups. All parturients who received fentanyl ≥ 15 μg had VAPS <20 mm and duration of analgesia > 15 min, but this was not true for all parturients with fentanyl doses <15 μg. Duration of analgesia was shorter for fentanyl groups 0, 5 and 10 μg, compared to groups 15, 20 and 25 μg, but there was no difference between the 15, 20 and 25 μg groups. There was no difference in the incidence of nausea and vomiting, or in FHR tracing changes. The incidence of pruritus was greater in all fentanyl groups compared to control. These data suggest that, when combined with intrathecal bupivacaine 2.5 mg, fentanyl 15 μg provides satisfactory analgesia to all parturients. Higher fentanyl doses produced no additional benefit in duration or quality of analgesia.

Original languageEnglish (US)
Pages (from-to)19-24
Number of pages6
JournalInternational Journal of Obstetric Anesthesia
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Bupivacaine
Fentanyl
Analgesia
Parturition
Fetal Heart Rate
Pain
Incidence
Pruritus
Lidocaine
Nausea
Epinephrine
Vomiting
Dilatation

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Anesthesiology and Pain Medicine

Cite this

Wong, Cynthia A. ; Scavone, B. M. ; Slavenas, J. P. ; Vidovich, M. I. ; Peaceman, Alan M ; Ganchiff, J. N. ; Strauss-Hoder, T. ; McCarthy, Robert J. / Efficacy and side effect profile of varying doses of intrathecal fentanyl added to bupivacaine for labor analgesia. In: International Journal of Obstetric Anesthesia. 2004 ; Vol. 13, No. 1. pp. 19-24.
@article{42006c906b384a318952796b902372f2,
title = "Efficacy and side effect profile of varying doses of intrathecal fentanyl added to bupivacaine for labor analgesia",
abstract = "The purpose of this randomized, double blinded and controlled study was to determine the optimal dose of intrathecal fentanyl when combined with bupivacaine 2.5 mg for initiation of labor analgesia. Parous parturients with cervical dilation between 3 and 5 cm were randomized to receive intrathecal fentanyl 0 (control), 5, 10, 15, 20 or 25 μg, combined with bupivacaine 2.5 mg, followed by a lidocaine/epinephrine epidural test dose. Visual analog pain scores (VAPS) and the presence of side effects were determined every 15 min until the parturient requested additional analgesia. Fetal heart rate (FHR) tracings were compared between groups. All parturients who received fentanyl ≥ 15 μg had VAPS <20 mm and duration of analgesia > 15 min, but this was not true for all parturients with fentanyl doses <15 μg. Duration of analgesia was shorter for fentanyl groups 0, 5 and 10 μg, compared to groups 15, 20 and 25 μg, but there was no difference between the 15, 20 and 25 μg groups. There was no difference in the incidence of nausea and vomiting, or in FHR tracing changes. The incidence of pruritus was greater in all fentanyl groups compared to control. These data suggest that, when combined with intrathecal bupivacaine 2.5 mg, fentanyl 15 μg provides satisfactory analgesia to all parturients. Higher fentanyl doses produced no additional benefit in duration or quality of analgesia.",
author = "Wong, {Cynthia A.} and Scavone, {B. M.} and Slavenas, {J. P.} and Vidovich, {M. I.} and Peaceman, {Alan M} and Ganchiff, {J. N.} and T. Strauss-Hoder and McCarthy, {Robert J}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/S0959-289X(03)00106-7",
language = "English (US)",
volume = "13",
pages = "19--24",
journal = "International Journal of Obstetric Anesthesia",
issn = "0959-289X",
publisher = "Churchill Livingstone",
number = "1",

}

Efficacy and side effect profile of varying doses of intrathecal fentanyl added to bupivacaine for labor analgesia. / Wong, Cynthia A.; Scavone, B. M.; Slavenas, J. P.; Vidovich, M. I.; Peaceman, Alan M; Ganchiff, J. N.; Strauss-Hoder, T.; McCarthy, Robert J.

In: International Journal of Obstetric Anesthesia, Vol. 13, No. 1, 01.01.2004, p. 19-24.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy and side effect profile of varying doses of intrathecal fentanyl added to bupivacaine for labor analgesia

AU - Wong, Cynthia A.

AU - Scavone, B. M.

AU - Slavenas, J. P.

AU - Vidovich, M. I.

AU - Peaceman, Alan M

AU - Ganchiff, J. N.

AU - Strauss-Hoder, T.

AU - McCarthy, Robert J

PY - 2004/1/1

Y1 - 2004/1/1

N2 - The purpose of this randomized, double blinded and controlled study was to determine the optimal dose of intrathecal fentanyl when combined with bupivacaine 2.5 mg for initiation of labor analgesia. Parous parturients with cervical dilation between 3 and 5 cm were randomized to receive intrathecal fentanyl 0 (control), 5, 10, 15, 20 or 25 μg, combined with bupivacaine 2.5 mg, followed by a lidocaine/epinephrine epidural test dose. Visual analog pain scores (VAPS) and the presence of side effects were determined every 15 min until the parturient requested additional analgesia. Fetal heart rate (FHR) tracings were compared between groups. All parturients who received fentanyl ≥ 15 μg had VAPS <20 mm and duration of analgesia > 15 min, but this was not true for all parturients with fentanyl doses <15 μg. Duration of analgesia was shorter for fentanyl groups 0, 5 and 10 μg, compared to groups 15, 20 and 25 μg, but there was no difference between the 15, 20 and 25 μg groups. There was no difference in the incidence of nausea and vomiting, or in FHR tracing changes. The incidence of pruritus was greater in all fentanyl groups compared to control. These data suggest that, when combined with intrathecal bupivacaine 2.5 mg, fentanyl 15 μg provides satisfactory analgesia to all parturients. Higher fentanyl doses produced no additional benefit in duration or quality of analgesia.

AB - The purpose of this randomized, double blinded and controlled study was to determine the optimal dose of intrathecal fentanyl when combined with bupivacaine 2.5 mg for initiation of labor analgesia. Parous parturients with cervical dilation between 3 and 5 cm were randomized to receive intrathecal fentanyl 0 (control), 5, 10, 15, 20 or 25 μg, combined with bupivacaine 2.5 mg, followed by a lidocaine/epinephrine epidural test dose. Visual analog pain scores (VAPS) and the presence of side effects were determined every 15 min until the parturient requested additional analgesia. Fetal heart rate (FHR) tracings were compared between groups. All parturients who received fentanyl ≥ 15 μg had VAPS <20 mm and duration of analgesia > 15 min, but this was not true for all parturients with fentanyl doses <15 μg. Duration of analgesia was shorter for fentanyl groups 0, 5 and 10 μg, compared to groups 15, 20 and 25 μg, but there was no difference between the 15, 20 and 25 μg groups. There was no difference in the incidence of nausea and vomiting, or in FHR tracing changes. The incidence of pruritus was greater in all fentanyl groups compared to control. These data suggest that, when combined with intrathecal bupivacaine 2.5 mg, fentanyl 15 μg provides satisfactory analgesia to all parturients. Higher fentanyl doses produced no additional benefit in duration or quality of analgesia.

UR - http://www.scopus.com/inward/record.url?scp=0346458921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346458921&partnerID=8YFLogxK

U2 - 10.1016/S0959-289X(03)00106-7

DO - 10.1016/S0959-289X(03)00106-7

M3 - Article

VL - 13

SP - 19

EP - 24

JO - International Journal of Obstetric Anesthesia

JF - International Journal of Obstetric Anesthesia

SN - 0959-289X

IS - 1

ER -